sacituzumab,deruxtecan
gilead sciences,daiichi sankyo
['rux,(-crux),(-trux)', 'tnbc', 'sacituzumab', 'bcsm']
 #esmo22 while no randomized trials solve the question, in #tnbc #bcsm #sacituzumab #deruxtecan : who wins? 
Medical Oncology at https://t.co/hCfxKt8kbP and https://t.co/YeizvuTGR3 Opinions are my own.